Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The in vitro antimicrobial activity of wound and skin cleansers at nontoxic concentrations.

Rani SA, Hoon R, Najafi RR, Khosrovi B, Wang L, Debabov D.

Adv Skin Wound Care. 2014 Feb;27(2):65-9. doi: 10.1097/01.ASW.0000443255.73875.a3.

PMID:
24440863
2.

A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes.

Wilson JR, Mills JG, Prather ID, Dimitrijevich SD.

Adv Skin Wound Care. 2005 Sep;18(7):373-8.

PMID:
16160464
3.

Bactericidal and cytotoxic effects of chloramine-T on wound pathogens and human fibroblasts in vitro.

Kloth LC, Berman JE, Laatsch LJ, Kirchner PA.

Adv Skin Wound Care. 2007 Jun;20(6):331-45.

PMID:
17538259
4.

The Bactericidal And Cytotoxic Effects Of Antimicrobial Wound Cleansers.

Rabenberg VS, Ingersoll CD, Sandrey MA, Johnson MT.

J Athl Train. 2002 Mar;37(1):51-54.

5.

In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.

Desbois AP, Gemmell CG, Coote PJ.

Int J Antimicrob Agents. 2010 Jun;35(6):559-65. doi: 10.1016/j.ijantimicag.2010.01.016. Epub 2010 Mar 4.

PMID:
20206480
6.

Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.

Vingsbo Lundberg C, Frimodt-Møller N.

Int J Antimicrob Agents. 2013 Sep;42(3):272-5. doi: 10.1016/j.ijantimicag.2013.05.008. Epub 2013 Jul 6.

PMID:
23837927
7.

Application of orange essential oil as an antistaphylococcal agent in a dressing model.

Muthaiyan A, Biswas D, Crandall PG, Wilkinson BJ, Ricke SC.

BMC Complement Altern Med. 2012 Aug 16;12:125. doi: 10.1186/1472-6882-12-125.

8.

[The antimicrobial activity and cytotoxicity of anti-infective preparations in a human cell-culture model].

Afinogenov GE, Eropkina EM, Bondarenko VM, Eropkin MIu.

Zh Mikrobiol Epidemiol Immunobiol. 1996 Sep-Oct;(5):3-7. Russian.

PMID:
9082724
9.

Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice.

Heunis TD, Smith C, Dicks LM.

Antimicrob Agents Chemother. 2013 Aug;57(8):3928-35. doi: 10.1128/AAC.00622-13. Epub 2013 Jun 3.

10.

Fibroblast cytotoxicity and blood cell integrity following exposure to dermal wound cleansers.

Wright RW Jr, Orr R.

Ostomy Wound Manage. 1993 Sep;39(7):33-6, 38, 40.

PMID:
8311898
11.

In vitro evaluation of the antimicrobial efficacy of a new silver-triclosan vs a silver collagen-coated polyester vascular graft against methicillin-resistant Staphylococcus aureus.

Ricco JB, Assadian A, Schneider F, Assadian O.

J Vasc Surg. 2012 Mar;55(3):823-9. doi: 10.1016/j.jvs.2011.08.015. Epub 2011 Nov 10.

12.

Antimicrobial properties of 8-hydroxyserrulat-14-en-19-oic acid for treatment of implant-associated infections.

Nowakowska J, Griesser HJ, Textor M, Landmann R, Khanna N.

Antimicrob Agents Chemother. 2013 Jan;57(1):333-42. doi: 10.1128/AAC.01735-12. Epub 2012 Oct 31.

13.

Comparative in vitro activities of topical wound care products against community-associated methicillin-resistant Staphylococcus aureus.

Bearden DT, Allen GP, Christensen JM.

J Antimicrob Chemother. 2008 Oct;62(4):769-72. doi: 10.1093/jac/dkn272. Epub 2008 Jun 30.

14.

Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts.

Hidalgo E, Bartolomé R, Barroso C, Moreno A, Domínguez C.

Skin Pharmacol Appl Skin Physiol. 1998 May-Jun;11(3):140-51.

PMID:
9745141
15.

Effects of 4-chloro-2,6-bis-(2-hydroxyl-benzyl)-phenol on healing of skin wounds and growth of bacteria.

Oryan A, Khalafi-Nezhad A, Toloo N, Soltani Rad MN.

J Vet Med A Physiol Pathol Clin Med. 2007 Dec;54(10):585-91.

PMID:
18045344
16.

Innate defense regulator peptide 1018 in wound healing and wound infection.

Steinstraesser L, Hirsch T, Schulte M, Kueckelhaus M, Jacobsen F, Mersch EA, Stricker I, Afacan N, Jenssen H, Hancock RE, Kindrachuk J.

PLoS One. 2012;7(8):e39373. doi: 10.1371/journal.pone.0039373. Epub 2012 Aug 6.

17.

Controlling methicillin resistant Staphyloccocus aureus and Pseudomonas aeruginosa wound infections with a novel biomaterial.

Martineau L, Davis SC, Peng HT, Hung A.

J Invest Surg. 2007 Jul-Aug;20(4):217-27. Erratum in: J Invest Surg. 2008 Nov-Dec;21(6):375. Peng, Henry T [added]; Hung, Andy [added].

PMID:
17710602
18.

Use of the antimicrobial peptide pardaxin (GE33) to protect against methicillin-resistant Staphylococcus aureus infection in mice with skin injuries.

Huang HN, Pan CY, Chan YL, Chen JY, Wu CJ.

Antimicrob Agents Chemother. 2014;58(3):1538-45. doi: 10.1128/AAC.02427-13. Epub 2013 Dec 23.

19.

Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells.

Loughlin R, Gilmore BF, McCarron PA, Tunney MM.

Lett Appl Microbiol. 2008 Apr;46(4):428-33. doi: 10.1111/j.1472-765X.2008.02334.x. Epub 2008 Feb 22.

20.

Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus.

Haley CE, Marling-Cason M, Smith JW, Luby JP, Mackowiak PA.

J Clin Microbiol. 1985 Jun;21(6):991-2.

Items per page

Supplemental Content

Write to the Help Desk